Real world outcomes for treatment of diffuse large B cell Lymphoma in patients aged 80 and over

被引：0
|
作者：
Cooke, R. [1 ]
Williams, C. [2 ]
Holmes, G. [2 ]
机构：
[1] Northumbria Healthcare NHS Trust, Newcastle Upon Tyne, Tyne & Wear, England
[2] Northumbria Healthcare NHS Trust, Haematol, Newcastle Upon Tyne, Tyne & Wear, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH2020-EP
引用
收藏
页码：233 / 234
页数：2
相关论文
共 50 条
  • [1] Comparison of outcomes among patients aged 80 and over and younger patients with diffuse large B-cell lymphoma: a population based study
    Varga, Cindy
    Holcroft, Christina
    Kezouh, Abbas
    Bucatel, Serghei
    Johnson, Nathalie
    Petrogiannis-Haliotis, Tina
    Assouline, Sarit
    LEUKEMIA & LYMPHOMA, 2014, 55 (03) : 533 - 537
  • [2] Real World Characteristics and Outcomes of Patients with Relapsed and Refractory Diffuse Large B Cell Lymphoma; A Provincial Experience
    Manji, Farheen
    Stewart, Douglas A.
    BLOOD, 2020, 136
  • [3] Real-world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B-cell lymphoma by line of therapy
    Sineshaw, Helmneh M.
    Zettler, Christina M.
    Prescott, Jennifer
    Garg, Mahek
    Chakraborty, Samhita
    Sarpong, Eric M.
    Bai, Claire
    Belli, Andrew J.
    Fernandes, Laura L.
    Wang, Ching-Kun
    CANCER MEDICINE, 2024, 13 (07):
  • [4] Real-world outcomes of diffuse large B-cell lymphoma in the biosimilar era
    Nair, Reena
    Bhat, Gull Mohammad
    Agrawal, Narendra
    Sengar, Manju
    Malhotra, Pankaj
    Nityanand, Soniya
    Lele, Chitra
    Reddy, Pramod
    Kankanwadi, Suresh
    Maharaj, Narendra
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [5] R-CVP regimen is active in frail elderly patients aged 80 or over with diffuse large B cell lymphoma
    Kamel Laribi
    Nathalie Denizon
    Delphine Bolle
    Catherine Truong
    Anne Besançon
    Jeremy Sandrini
    Andreaa Anghel
    Jonathan Farhi
    Habib Ghnaya
    Alix Baugier de Materre
    Annals of Hematology, 2016, 95 : 1705 - 1714
  • [6] R-CVP regimen is active in frail elderly patients aged 80 or over with diffuse large B cell lymphoma
    Laribi, Kamel
    Denizon, Nathalie
    Bolle, Delphine
    Truong, Catherine
    Besanon, Anne
    Sandrini, Jeremy
    Anghel, Andreaa
    Farhi, Jonathan
    Ghnaya, Habib
    de Materre, Alix Baugier
    ANNALS OF HEMATOLOGY, 2016, 95 (10) : 1705 - 1714
  • [7] A safe and effective immunochemotherapy with oral sobuzoxane and etoposide for untreated diffuse large B cell lymphoma patients aged 80 and over
    Miyashita, K.
    Utsunomiya, W.
    Hirata, K.
    Higuchi, M.
    Tachikawa, Y.
    Choi, I.
    Suehiro, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S547 - S547
  • [8] Determination of the appropriate chemotherapy for patients aged 80 years or older with diffuse large B cell lymphoma
    Kim, Min Jung
    Cho, Junhun
    Kim, Won Seog
    Kim, Seok Jin
    Yoon, Sang Eun
    LEUKEMIA & LYMPHOMA, 2025,
  • [9] Retrospective Analysis of Real-World Outcomes in Older Adult Patients With Diffuse Large B-Cell Lymphoma
    Jobanputra, Kunal
    Nayak, Lingaraj
    Jain, Hasmukh
    Bonda, V. N. Avinash
    Thorat, Jayashree
    Bagal, Bhausaheb
    Sengar, Manju
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S372 - S373
  • [10] A retrospective analysis of real-world outcomes of elderly Chinese patients with diffuse large B-cell lymphoma
    Liu Peng
    Han Ying
    Jiang Shi-Yu
    He Xiao-Hui
    Qin Yan
    Gui Lin
    Zhou Sheng-Yu
    Zhou Li-Qiang
    Yang Jian- Liang
    Yang Sheng
    Wen Ting-Yu
    Shi Yuan-Kai
    中华医学杂志英文版, 2019, 132 (15) : 1807 - 1814
12345